MTOR and neoplasm: Oncogenic alterations within the RAS/RAF/MEK/ERK cascade and FGFR fusions converge on the PI3K/Akt/mTOR axis, resulting in sustained pathway activation that promotes uncontrolled proliferation, tumor progression, and metastatic dissemination [39].